This study and others demonstrate results similar to ours, indicating that overexpression of MIR100HG may contribute to the progression of CRC and could be a potential therapeutic target and prognostic biomarker for patients with CRC [50, 52, 53]. Here, MIR100HG is linked to colorectal carcinoma.